glp 1 pfizer In the same week that decided to discontinue the development of danuglipron, an oral, small-molecule GLP-1 receptor agonist aimed at chronic weight management ➡️ Lilly report a successful Phase 3 trial GLP-1 medications mimic the effects

[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Lally P, van Jaarsveld CHM, Potts HWW, Wardle J

Saxena R, Saxena RR, Saxena AR (2018) Microbiomics in the molecular era: a birds eye view into the future of personalized medicine

doi: 10.3389/fphar.2021.706908 Received 08 May 2021 Accepted 29 June 2021 Published 14 July 2021 Volume 12 - 2021 Edited by Hong Zhou, Zunyi Medical University, China Reviewed by Weiying Zhou, Chongqing Medical University, China Xin Liu, Third Military Medical University, China Updates Copyright 2021 Yang, Zeng, Luo, Lei, Li, Lu, Huang, Lan and Liu

Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants